Related references
Note: Only part of the references are listed.The therapeutic potential of galectin-3 inhibition in fibrotic disease
R. J. Slack et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)
Relationship of Galectin-3 Expression in Canine Cutaneous Squamous Cell Carcinomas with Histopathological Grading and Proliferation Indices
G. R. Marques et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2020)
Limited contribution of left ventricularmass and remodelling to the impact of blood pressure on diastolic function in a community sample
Adamu J. Bamaiyi et al.
JOURNAL OF HYPERTENSION (2019)
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
Bruce W. Keene et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Therapies in Canine Atopic Dermatitis: An Update
Domenico Santoro
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2019)
Use of speckle tracking to assess heart failure with preserved ejection fraction
John B. Hiebert et al.
JOURNAL OF CARDIOLOGY (2019)
Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study
Amy Vora et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Galectin-3 Expression Correlates with Post-surgical Survival in Canine Oral Melanomas
T. H. M. Vargas et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2019)
Alteration of Cardiac Performance and Serum B-Type Natriuretic Peptide Level in Healthy Aging
Yuriko Yoshida et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping
Zhen Zhou et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy
Rui Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients
Z. Shi et al.
LUPUS (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Galectin-3 in Heart Failure An Update of the Last 3 Years
Carolin Gehlken et al.
HEART FAILURE CLINICS (2018)
Changes of cardiac function in diabetic dogs
P. Vichit et al.
JOURNAL OF VETERINARY CARDIOLOGY (2018)
N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review
Gabriela Vieira de Lima et al.
VETERINARY WORLD (2017)
Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy
Bruno Solana de Freitas Souza et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study
Julija Brozaitiene et al.
BMC CARDIOVASCULAR DISORDERS (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
The Relationship between Galectin-3 and Different Patterns of Ventricular Geometry Remodelling in Aortic Valve Stenosis
Kang Zhou et al.
HEART LUNG AND CIRCULATION (2016)
An update on the treatment of canine atopic dermatitis
Manolis N. Saridomichelakis et al.
VETERINARY JOURNAL (2016)
How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing
A. E. Huis in 't Veld et al.
NETHERLANDS HEART JOURNAL (2016)
Galectin-3 in cardiac muscle and circulation of dogs with degenerative mitral valve disease
S. Sakarin et al.
JOURNAL OF VETERINARY CARDIOLOGY (2016)
The Role of Galectin-3 in the Kidneys
Szu-Chia Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
OP-178 Galectin-3 Levels in Hypertrophic Cardiomyopathy and the Relationship with Left Ventricular Mass Index and Function
Selcen Yakar Tuluce et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression
Xiang Song et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
Patrick Hensel et al.
BMC VETERINARY RESEARCH (2015)
Galectin-3 is expressed in the myocardium very early post-myocardial infarction
Satwat Hashmi et al.
CARDIOVASCULAR PATHOLOGY (2015)
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy
Giuseppe Vergaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort
Annika Jagodzinski et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies
Christiane Drechsler et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices
Cho-Kai Wu et al.
SCIENTIFIC REPORTS (2015)
Serum Galectin-3 as a Potential Marker for Gastric Cancer
Yunhui Li
MEDICAL SCIENCE MONITOR (2015)
Left ventricular structural and functional abnormalities in dogs with hyperadrenocorticism
Hiroshi Takano et al.
JOURNAL OF VETERINARY CARDIOLOGY (2015)
Relationship of Plasma N- terminal Pro- brain Natriuretic Peptide Concentrations to Heart Failure Classification and Cause of Respiratory Distress in Dogs Using a 2nd Generation ELISA Assay
P. R. Fox et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials
Wouter C. Meijers et al.
AMERICAN HEART JOURNAL (2014)
Sensitization rates of causative allergens for dogs with atopic dermatitis: detection of canine allergen-specific IgE
Min-Hee Kang et al.
JOURNAL OF VETERINARY SCIENCE (2014)
Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs
Richard K. Burchell et al.
JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION (2014)
Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease
Melanie J. Hezzell et al.
JOURNAL OF VETERINARY CARDIOLOGY (2014)
Cardiac Troponin-I Concentration, Myocardial Arteriosclerosis, and Fibrosis in Dogs with Congestive Heart Failure because of Myxomatous Mitral Valve Disease
T. Falk et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2013)
Clinical assessment of systolic myocardial deformations in dogs with chronic mitral valve insufficiency using two-dimensional speckle-tracking echocardiography
Ryohei Suzuki et al.
JOURNAL OF VETERINARY CARDIOLOGY (2013)
Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome
Kai Hang Yiu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Patterns of left ventricular remodeling in chronic heart failure: Prevalence and prognostic implications
Frank Lloyd Dini et al.
AMERICAN HEART JOURNAL (2011)
Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
W. H. Wilson Tang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Galectin-3 and the skin
Larissa Larsen et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Galectin-3: A Novel Blood Test for the Evaluation and Management of Patients With Heart Failure
Peter A. McCullough et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2011)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
The relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in cardiovascular patients
Roman Pfister et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Associations between cardiac pathology and clinical, echocardiographic and electrocardiographic findings in dogs with chronic congestive heart failure
Torkel Falk et al.
VETERINARY JOURNAL (2010)
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Yun-He Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
Yen-Hung Lin et al.
CLINICA CHIMICA ACTA (2009)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2009)
Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction
Anastasia S. Mihailidou et al.
HYPERTENSION (2009)
Mineralocorticoid receptor activation and cardiac fibrosis
Morag J. Young et al.
CLINICAL SCIENCE (2007)
Diagnosis of hyperadrenocorticism in dogs
Mark E. Peterson
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Left ventricular structural and functional characteristics in Cushing's syndrome
ML Muiesan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
Share Paper
